The ENT Quality Improvement Program (QIP) as a tool to improve the quality of morbidity and mortality (M+M) data collection

Author(s):  
Rachel Edmiston
2019 ◽  
Vol 8 (3) ◽  
pp. e000501 ◽  
Author(s):  
Rachel Edmiston ◽  
Rajesh Anmolsingh ◽  
Sadie Khwaja ◽  
B Nirmal Kumar

ObjectiveThis project aims to assess the role of a standardised process of data collection to improve morbidity and mortality data across the region.DesignSix hospitals within the North West (UK) were recruited and adopted the ENT Quality Improvement Program (QIP) into their daily practice. Monthly anonymous data were sent back to the reviewer for trend analysis.Outcome measuresFour outcome measures were defined: (1) number of cases recorded within the region each month; (2) assessment of the severity of cases and trends; (3) assessment of action plans reviewing any changes in practice made as a result of using this tool; (4) long-term use of the tool and qualitative feedback from units.Results162 patients over the 6 months were included with 180 case discussions. 170 of these were morbidities and 10 were mortalities. Mortality was more frequent in patients with a diagnosis of head and neck cancer. Of the 162 patients, 133 encountered postoperative complications. Post-tonsillectomy (62/133 47%) and post-thyroid surgery (19/133 14%) complications were the most frequently encountered. 66% of the complications were low grade with 18% requiring management under general anaesthetic. Actions plans included four policy reviews with the introduction of three new policies. All sites found the tool user-friendly and are continuing to use it beyond the data collection period.ConclusionsThe ENT QIP has been found to be a simple, user-friendly tool which has improved the quality of data over the six sites and resulted in improvements in practice. Implementation of the tool allows clinicians to critically appraise their practice and to reflect as well as to demonstrate how complications have resulted in change.


Diabetes Care ◽  
2008 ◽  
Vol 31 (11) ◽  
pp. 2166-2168 ◽  
Author(s):  
M. C.E. Rossi ◽  
A. Nicolucci ◽  
A. Arcangeli ◽  
A. Cimino ◽  
G. De Bigontina ◽  
...  

2011 ◽  
Vol 77 (7) ◽  
pp. 832-838 ◽  
Author(s):  
William B. Newton ◽  
Matthew J. Sagransky ◽  
Jeanette S. Andrews ◽  
Kimberly J. Hansen ◽  
Matthew A. Corriere ◽  
...  

This report examines outcomes of revascularization for acute arterial mesenteric ischemia (AAMI) using the American College of Surgeons National Surgical Quality Improvement Program database. Patients with International Classification of Diseases, 9th Revision and Current Procedural Terminology codes indicating AAMI with concomitant mesenteric revascularization were identified. Demographic, risk factor, procedural, morbidity, and mortality data were examined. Associations with morbidity and mortality were analyzed by logistic regression. One hundred forty-two cases of AAMI were identified. Seventy-one cases were thrombotic and 71 were embolic according to revascularization codes. Mean age was 66 years, 84 per cent of patients were white, and 54 per cent were female. Unadjusted major morbidity and mortality rates were 69 and 30 per cent, respectively. Patients with thrombotic AAMI were more likely to have a lower body mass index, greater than 10 per cent weight loss in the past 6 months, and a history of smoking. Patients with embolic AAMI were more likely to present emergently with sepsis. Unadjusted morbidity and mortality rates were 78 and 38 per cent for embolic and 61 and 23 per cent for thrombotic AAMI, respectively. Multi-variable predictors of morbidity included bowel resection at the time of revascularization, transfer admission, and involvement of a surgical resident. Multivariable predictors of mortality included impaired functional status, increased age, and postoperative sepsis. Cause of AAMI was not a significant predictor of morbidity or mortality. In a large sample of AAMI cases, AAMI remained a highly lethal and morbid condition. Predictors of morbidity and mortality included indicators of advanced presentation, treatment delay, and patient-related factors specific to AAMI, including debility and advanced age. Efforts directed at prevention and increasing the speed of diagnosis and definitive treatment appear to be necessary to improve outcomes.


Sign in / Sign up

Export Citation Format

Share Document